Literature DB >> 26123465

Intrapleural cisplatin for management of malignant pleural effusion in a patient with plasma cell leucaemia.

Abhishek Agarwal1, Jagpal Klair2, Setu Patolia3, Nikhil K Meena4.   

Abstract

Plasma cell leucaemia (PCL) is a rare aggressive form of multiple myeloma. It occasionally involves the pleura, causing malignant pleural effusion (MPE). MPE presents a management dilemma for physicians, given the different treatment options available with varying efficacy and side effects. We report a case of a 64-year-old man with MPE due to PCL, successfully managed with intrapleural cisplatin and a tunnelled pleural catheter. We believe this to be the first report of management of PCL-associated MPE with intrapleural cisplatin. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26123465      PMCID： PMC4488616          DOI： 10.1136/bcr-2015-210044

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  14 in total

1.  Use of intrapleural bortezomib in myelomatous pleural effusion.

Authors:  Emilio Iannitto; Viviana Minardi; Claudio Tripodo
Journal:  Br J Haematol       Date:  2007-11       Impact factor: 6.998

2.  A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical intervention.

Authors:  Yukito Ichinose; Ryosuke Tsuchiya; Teruaki Koike; Tsutomu Yasumitsu; Kenji Nakamura; Hirohito Tada; Hirokuni Yoshimura; Tetsuya Mitsudomi; Ken Nakagawa; Kohei Yokoi; Harubumi Kato
Journal:  J Thorac Cardiovasc Surg       Date:  2002-04       Impact factor: 5.209

3.  A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions.

Authors:  K C Ong; V Indumathi; J Raghuram; Y Y Ong
Journal:  Respirology       Date:  2000-06       Impact factor: 6.424

4.  Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.

Authors:  Shaohua Ren; David S Terman; Greg Bohach; Abraham Silvers; Chris Hansen; Henri Colt; Steven A Sahn
Journal:  Chest       Date:  2004-11       Impact factor: 9.410

Review 5.  Pleurodesis for malignant pleural effusions.

Authors:  P Shaw; R Agarwal
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 6.  Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.

Authors:  C Fernández de Larrea; R A Kyle; B G M Durie; H Ludwig; S Usmani; D H Vesole; R Hajek; J F San Miguel; O Sezer; P Sonneveld; S K Kumar; A Mahindra; R Comenzo; A Palumbo; A Mazumber; K C Anderson; P G Richardson; A Z Badros; J Caers; M Cavo; X LeLeu; M A Dimopoulos; C S Chim; R Schots; A Noeul; D Fantl; U-H Mellqvist; O Landgren; A Chanan-Khan; P Moreau; R Fonseca; G Merlini; J J Lahuerta; J Bladé; R Z Orlowski; J J Shah
Journal:  Leukemia       Date:  2012-11-21       Impact factor: 11.528

7.  Primary plasma cell leukemia: a Surveillance, Epidemiology, and End Results database analysis between 1973 and 2004.

Authors:  Giridharan Ramsingh; Paul Mehan; Jingqin Luo; Ravi Vij; Daniel Morgensztern
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

8.  Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.

Authors:  V W Rusch; R Figlin; D Godwin; S Piantadosi
Journal:  J Clin Oncol       Date:  1991-02       Impact factor: 44.544

9.  Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research.

Authors:  A Mahindra; M E Kalaycio; J Vela-Ojeda; D H Vesole; M-J Zhang; P Li; J R Berenson; J M Bird; A Dispenzieri; J L Gajewski; R P Gale; L Holmberg; S Kumar; R A Kyle; H M Lazarus; S Lonial; J Mikhael; G A Milone; R Munker; R Nath; S Saccaro; L Bik To; D T Vogl; B Wirk; P Hari
Journal:  Leukemia       Date:  2011-11-01       Impact factor: 11.528

Review 10.  Malignant pleural effusion: medical approaches for diagnosis and management.

Authors:  Hae-Seong Nam
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-05-29
View more
  1 in total

1.  A single institution experience for the management of recurrent pleural effusions with tunneled pleural catheter and its evolution.

Authors:  Tuhina Raman; Nikhil Meena
Journal:  Ther Adv Respir Dis       Date:  2017-08-11       Impact factor: 4.031
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.